Hexaware: AI shifts vendor dynamics
Hexaware argued that pharma and life‑sciences firms are moving from traditional vendors to AI value partnerships—emphasizing outcome‑focused relationships over product sales. That positioning is a sales talking point when buyers ask how your platform creates measurable revenue or trial outcomes. (x.com)
Hexaware announced a strategic partnership with CareInsight on Feb. 12, 2026 to deliver production‑grade, outcome‑based AI deployments for healthcare organizations at enterprise scale. (prnewswire.com)) The CareInsight release states the deal will operationalize AI across core administrative and clinical workflows to produce measurable improvements in operations, decision‑making and care delivery. (hexaware.com)) On July 10, 2025 Hexaware formed a life‑sciences alliance with Abluva to develop governed, agentic AI solutions aimed at sponsors and CROs. (hexaware.com)) Those Abluva materials highlight embedded governance and audit capabilities and promote a Secure Intelligence Plane designed to reduce regulatory and data‑privacy risk for autonomous AI agents. (prnewswire.com)) Company releases name Shantanu Baruah as President & Global Head — Healthcare, Life Sciences & Insurance and Raj Gondhali as AVP & Head of Clinical Solutions in the teams leading these healthcare and life‑sciences initiatives. (d28y8cu0ilslnd.cloudfront.net)) Hexaware’s announcements include its market identifier (NSE: HEXT) and list a U.S. presence in Iselin, New Jersey on the company’s office pages. (prnewswire.com)) Hexaware’s 2026 communications also point to third‑party recognition—Brand Finance placing the firm in its 'IT Services 25 2026' and ISG naming Hexaware a 'Top 15 Sourcing Standout'—details the company uses in public messaging. (leadiq.com))
